KR890700033A - 외상치료 및 뼈 재생 - Google Patents

외상치료 및 뼈 재생

Info

Publication number
KR890700033A
KR890700033A KR1019880700829A KR880700829A KR890700033A KR 890700033 A KR890700033 A KR 890700033A KR 1019880700829 A KR1019880700829 A KR 1019880700829A KR 880700829 A KR880700829 A KR 880700829A KR 890700033 A KR890700033 A KR 890700033A
Authority
KR
South Korea
Prior art keywords
growth factor
purified
composition
mammal
trauma
Prior art date
Application number
KR1019880700829A
Other languages
English (en)
Other versions
KR960005708B1 (ko
Inventor
엔.안토니아즈 해리
시.윌리암스 레이
이.린치 사무엘
Original Assignee
원본미기재
인스티튜트 오브 몰레큘러 바이올로지, 인코오포레이티드
프레지던트 앤드 펠로우즈 오브 하바드 콜리지
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 인스티튜트 오브 몰레큘러 바이올로지, 인코오포레이티드, 프레지던트 앤드 펠로우즈 오브 하바드 콜리지 filed Critical 원본미기재
Publication of KR890700033A publication Critical patent/KR890700033A/ko
Application granted granted Critical
Publication of KR960005708B1 publication Critical patent/KR960005708B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

외상치료 및 뼈 재생
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 정제된 혈소판-유도된 성장인자와 정제된 인슐린-형 성장 인자로 구성된 조성물의 상처-치료적양을 포유류의 상처에 적용하는 것으로 구성된 포유류의 외상을 치료하는 방법.
  2. 정제된 혈소판-유도된 성장 인자와 정제된 인슐린-형 성장인자로 구성된 조성물의 상처-치료적양을 포유류에 투여하는 것으로 구성된 포유류의 뼈의 재생방법.
  3. 제1항 또는 제2항에 있어서, 상기 조성물내의 상기 혈소판-유도된 성장인자와 상기 인슐린-형 성장인자의 중량대 중량비율이 1：4 내지 25：1인 방법.
  4. 제3항에 있어서, 상기 비율이 1：2와 10：1 사이인 방법.
  5. 제4항에 있어서, 상기 비율이 1：1 또는 2：1 방법.
  6. 정제된 혈소판유도된 성장인자와 정제된 인슐린형 성장인자가 중량비 1：4 내지 25：1 구성된 외상치료 및 뼈 재생용 조성물.
  7. 제6항에 있어서, 상기 비율이 1：2와 10：1인 사이인 조성물.
  8. 제7항에 있어서, 상기 비율이 1：1 또는 2：1 인 조성물.
  9. 정제된 혈소판-유도된 성장인자와 정제된 인슐린-형 성장인자가 중량비로 1:4 내지 25:1로 혼합하는 것으로 구성된 외상치료용 조성물의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880700829A 1986-11-14 1987-11-13 외상 치료 및 뼈 재생용 조성물 KR960005708B1 (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US93076286A 1986-11-14 1986-11-14
US930,762 1986-11-14
US930762 1986-11-14
PCT/US1987/002975 WO1988003409A1 (en) 1986-11-14 1987-11-13 Wound healing and bone regeneration

Publications (2)

Publication Number Publication Date
KR890700033A true KR890700033A (ko) 1989-03-02
KR960005708B1 KR960005708B1 (ko) 1996-05-01

Family

ID=25459724

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880700829A KR960005708B1 (ko) 1986-11-14 1987-11-13 외상 치료 및 뼈 재생용 조성물

Country Status (15)

Country Link
EP (1) EP0289584B1 (ko)
JP (1) JPH01500199A (ko)
KR (1) KR960005708B1 (ko)
CN (1) CN1027346C (ko)
AT (1) ATE88899T1 (ko)
AU (1) AU600069B2 (ko)
DE (1) DE3785758T2 (ko)
DK (1) DK175889B1 (ko)
IE (1) IE60517B1 (ko)
MX (1) MX170454B (ko)
NO (1) NO883127L (ko)
NZ (1) NZ222551A (ko)
OA (1) OA09159A (ko)
WO (1) WO1988003409A1 (ko)
ZA (1) ZA878566B (ko)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4849407A (en) * 1986-08-13 1989-07-18 Zymogenetics, Inc. Biologically active mosaic proteins
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
ZA9010332B (en) * 1989-12-22 1991-08-28 Ciba Geigy Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
WO1991015231A1 (en) * 1990-04-10 1991-10-17 Institute Of Molecular Biology, Inc. Wound healing
JP3377524B2 (ja) * 1990-05-30 2003-02-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 創傷治癒
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US7196054B1 (en) 1990-11-27 2007-03-27 The American National Red Cross Methods for treating wound tissue and forming a supplemented fibrin matrix
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
AU3062392A (en) * 1991-11-04 1993-06-07 Novo Nordisk A/S Pdgf gel formulation
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
JPH06510065A (ja) * 1992-06-08 1994-11-10 カイロン　コーポレーション 成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
CN1055023C (zh) * 1993-01-03 2000-08-02 周至譓 伤口护理剂
DK0804562T3 (da) 1994-07-12 2003-02-10 Human Genome Sciences Inc Bindevævsvækstfaktor-2
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
US5728676A (en) * 1994-09-08 1998-03-17 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
ATE274056T1 (de) * 1995-10-11 2004-09-15 Chiron Corp Kombination pdgf, kgf, igf und igfbp zur wundheilung
JP4275741B2 (ja) 1996-12-13 2009-06-10 ノバルティス バクシンズ アンド ダイアグノスティックス， インコーポレーテッド 血小板由来増殖因子タンパク質の分析および分離
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7241874B2 (en) 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
CN101370531A (zh) 2005-11-17 2009-02-18 生物模拟治疗公司 采用rhPDGF-BB和生物相容性基质的颌面骨增高
EP1991282B1 (en) 2006-02-09 2013-06-19 BioMimetic Therapeutics, LLC Compositions and methods for treating bone
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
EP2049145B1 (en) 2006-06-30 2018-03-14 BioMimetic Therapeutics, LLC Pdgf-biomatrix compositions and methods for treating rotator cuff injuries
EP2086598B1 (en) 2006-11-03 2015-05-27 BioMimetic Therapeutics, LLC Compositions and methods for arthrodetic procedures
ES2422259T3 (es) 2008-02-07 2013-09-10 Biomimetic Therapeutics Inc Composiciones para la osteogénesis por distracción
EP2341951A2 (en) 2008-09-09 2011-07-13 BioMimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
KR101959571B1 (ko) 2010-02-22 2019-03-18 바이오미메틱 세라퓨틱스, 인크. 건 질환의 치료를 위한 혈소판-유래 성장 인자 조성물 및 방법
CN102397534B (zh) * 2010-09-07 2013-10-23 中国人民解放军总医院 胰岛素在制备促进颌骨组织愈合的药物中的用途
WO2013077641A1 (ko) * 2011-11-22 2013-05-30 (주)아모레퍼시픽 성장 인자를 포함하는 피부 재생 촉진제
WO2016061219A1 (en) 2014-10-14 2016-04-21 Samuel Lynch Compositions for treating wounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor

Also Published As

Publication number Publication date
KR960005708B1 (ko) 1996-05-01
NZ222551A (en) 1989-11-28
IE60517B1 (en) 1994-07-27
EP0289584A1 (en) 1988-11-09
OA09159A (en) 1992-03-31
DK393288D0 (da) 1988-07-14
CN1027346C (zh) 1995-01-11
MX170454B (es) 1993-08-24
WO1988003409A1 (en) 1988-05-19
JPH01500199A (ja) 1989-01-26
DE3785758T2 (de) 1993-08-05
DE3785758D1 (de) 1993-06-09
DK393288A (da) 1988-09-13
IE873075L (en) 1988-05-14
JPH0581569B2 (ko) 1993-11-15
AU8328987A (en) 1988-06-01
NO883127L (no) 1988-09-12
ZA878566B (en) 1989-07-26
NO883127D0 (no) 1988-07-13
EP0289584A4 (en) 1990-01-08
EP0289584B1 (en) 1993-05-05
ATE88899T1 (de) 1993-05-15
AU600069B2 (en) 1990-08-02
DK175889B1 (da) 2005-05-30
CN87101250A (zh) 1988-06-08

Similar Documents

Publication Publication Date Title
KR890700033A (ko) 외상치료 및 뼈 재생
KR900700128A (ko) 외상 치료법
SE8703625D0 (sv) New medical use
NZ221806A (en) An adhesion-preventative barrier fabric containing heparin
BR9206433A (pt) Formulação e processo para tratar ferimentos.
ATE157542T1 (de) Verwendung von einer disaccharidpolysulfat- aluminium verbindung zur herstellung eines medikaments zur behandlung von hämorrhoiden und zur wundheilung
AU6567086A (en) Compositions and methods for the treatment of bleeding disorders
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69510775T2 (de) Methoden zur verwendung von cyclischenpolyanionischen polyderivatenzur kontrolle von hautfalten
ATE173401T1 (de) Neue verwendung von 1-alpha-hydroxylierten-19-nor-vitamin-d-verbind ngen zur behandlung von psoriasis
ES2174852T3 (es) Metodo para el tratamiento sistemico de estados catabolicos y lesiones sistemicas de tejidos.
DE69031218D1 (de) Wundheilung
DE3686022D1 (de) Monosaccharide enthaltende zusammensetzung zum heilen von wunden.
ES2178633T3 (es) Utilizacion concomitante del factor -i de crecimiento similar a insulina (en lo sucesivo "fci-i") y el factor de crecimiento transformante beta (en la sucesivo "fct-beta") para la fabricacion de un medicamento para la regeneracion de huesos en mamiferos.
DE69226525T2 (de) Verwendung von aus blutplättchen gewonnenem wachstumsfaktor zur herstellung eines medikaments zur behandlung von gastrointestinaler geschwüre
PH23594A (en) Method of promoting wound-healing
ATE178336T1 (de) Verwendung einer therapeutischen zusammensetzung zur behandlung von bronchitis
SU1113093A1 (ru) Способ лечени остеомиелита
DK563886A (da) Terapeutisk komposition
ATE56360T1 (de) Zusammensetzung zur herstellung eines arzneimittels zur therapeutischen behandlung von hauttrauma.
KR930700109A (ko) 신경 질환 치료용 4,4'-[9h-플루오렌-9-일리덴비스(메틸렌)]-비스피리미딘
KR890001568A (ko) 돼지 이질의 예방 및 치료제
NO942013L (no) Litiumsalt av 2-0-alkylaskorbinsyre
RU93029397A (ru) Способ использования медных производных хлорофилла для профилактики послеоперационных осложнений

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100429

Year of fee payment: 15

EXPY Expiration of term